Normal tissue tolerance to external beam radiation therapy: Liver;Dose de tolérance à l'irradiation des tissus sains: le foie

Cancer/Radiotherapie

Volumn 14, Issue 4-5, 2010, Pages 344-349

  De Bari, B ^a   Pointreau, Y ^b   Rio, E ^c   Mirabel, X ^d   Mornex, F ^a  

^a UNIVERSITÉ LYON 1   (France)

^b CHU BRETONNEAU   (France)

^c CENTRE RENÉ GAUDUCHEAU   (France)

^d CENTRE OSCAR LAMBRET   (France)

Author keywords

Ionizing radiation; Liver; NTCP; Organ at risk; Radiotherapy; Stereotactic; Tolerability

Indexed keywords

CANCER RADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; LIVER DISEASE; LIVER METASTASIS; LIVER TUMOR; NORMAL TISSUE COMPLICATION PROBABILITY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RADIOBIOLOGY; SHORT SURVEY; STEREOTACTIC BODY RADIATION THERAPY;

CHOLESTEROL; GLUCOSE; HEPATIC VEINS; HUMANS; LIPIDS; LIVER; LIVER NEOPLASMS; NEOPLASM METASTASIS; PORTAL VEIN; PROTEINS; RADIATION INJURIES; RADIATION TOLERANCE; RADIOSURGERY; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; VENA CAVA, INFERIOR;

EID: 77955318700     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2010.02.013     Document Type: Short Survey

References (31)

1. Borgelt B.B., Gelber R., Brady L.W., Griffin T., Hendrickson F.R. The palliation of hepatic metastases: results of the radiation therapy oncology group pilot study. Int J Radiat Oncol Biol Phys 1981, 7:587-591.
2. Casamassima F., Masi L., Menichelli C., D'Imporzano E., Polli C., Bonucci I. IGRT stereotactic hypofractionated radiotherapy for treatment of focal liver malignancies. Int J Radiat Oncol Biol Phys 2008, 72:S277-S278. [abstract].
3. Castaing D., René R., Azoulay D. Chapitre 1 « Anatomie du foie et des voies biliaires ». Chirurgie du foie et de l'hypertension portale 2006, 2-13. Masson, Issy-les-Moulineaux.
4. Chiou S.Y., Lee R.C., Chi K.H., Chia-Hsien C.J., Chiang J.H., Chang C.Y. The triple-phase CT image appearance of post-irradiated livers. Acta Radiol 2001, 42:526-531.
5. Couinaud C. Le foie. Études anatomiques et chirurgicales 1957, Masson et Cie, édit, Paris.
6. Dawson L.A. The evolving role of radiation therapy in hepatocellular carcinoma. Cancer Radiother 2008, 12:96-101.
7. Dawson L.A., Normolle D., Balter J.M., McGinn C.J., Lawrence T.S., Ten Haken R.K. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 2002, 53:810-821. [Erratum in: Int J Radiat Oncol Biol Phys 2002;53(5):1422. Comment in: Int J Radiat Oncol Biol Phys 2004;58(4):1318-19; author reply 1319-20].
8. Dawson L.A., Ten Haken R.K. Partial volume tolerance of the liver to radiation. Semin Radiat Oncol 2005, 15:279-283.
9. Dawson L.A., Ten Haken R.K., Lawrence T.S. Partial irradiation of the liver. Semin Radiat Oncol 2001, 11:240-246.
10. Emami B., Lyman J., Brown A., Coia L., Goitein M., Munzenrider J.E., et al. Tolerance of normal tissue to therapeutic radiation. Int J Radiat Oncol Biol Phys 1991, 21:109-122.
11. Hoyer M., Roed H., Traberg Hansen A., Ohlhuis L., Petersen J., Nellemann H., et al. Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol 2006, 45:823-830.
12. Ingold J.A., Reed G.B., Kaplan H.S., Bagshaw M.A. Radiation hepatitis. Am J Roentgenol 1965, 93:200-208.
13. Jackson A., Ten Haken R.K., Robertson J.M., Kessler M.L., Kutcher G.J., Lawrence T.S. Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. Int J Radiat Oncol Biol Phys 1995, 31:883-891.
14. Kallman P., Agren A., Brahme A. Tumour and normal tissue responses to fractionated non-uniform dose delivery. Int J Radiat Biol 1992, 62:249-262.
15. Katz A.W., Carey-Sampson M., Muhs A.G., Milano M.T., Schell M.C., Okunieff P. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys 2007, 67:793-798.
16. Kavanagh B.D., Schefter T.E., Cardenes H.R., Stieber V.W., Raben D., Timmerman R.D. Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncol 2006, 45:848-855.
17. Kehwar T.S. Analytical approach to estimate normal tissue complication probability using best fit of normal tissue tolerance doses into the NTCP equation of the linear quadratic model. J Cancer Res Ther 2005, 1:168-179.
18. Kutcher G.J., Lawrence T.S. Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. Int J Radiat Oncol Biol Phys 1995, 31:883-891.
19. Lawrence T.S., Robertson J.M., Anscher M.S., Jirtle R.L., Ensminger W.D., Fajardo L.F. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 1995, 31:1237-1248.
20. Lawrence T.S., Ten Haken R.K., Kessler M.L., Robertson J.M., Lyman J.T., Lavigne M.L., et al. The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys 1992, 23:781-788.
21. Lawrence T.S., Tesser R.J., Ten Haken R.K. An application of dose volume histograms to the treatment of intrahepatic malignancies with radiation therapy. Int J Radiat Oncol Biol Phys 1990, 19:1041-1047.
22. Leibel S.A., Guse C., Order S.E., Hendrickson F.R., Komaki R.U., Chang C.H., et al. Accelerated fractionation radiation therapy for liver metastases: selection of an optimal patient population for the evaluation of late hepatic injury in RTOG studies. Int J Radiat Oncol Biol Phys 1990, 18:523-528.
23. Milano M.T., Constine L.S., Okunieff P. Normal tissue toxicity after small field hypofractionated stereotactic body radiation. Radiat Oncol 2008, 3:36. [review].
24. Prasad B., Lee M.S., Hendrickson F.R. Irradiation of hepatic metastases. Int J Radiat Oncol Biol Phys 1977, 2:129-132.
25. Russell A.H., Clyde C., Wasserman T.H., Turner S.S., Rotman M. Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: results of the RTOG dose escalating protocol. Int J Radiat Oncol Biol Phys 1993, 27:117-123.
26. Schefter T.E., Kavanagh B.D., Timmerman R.D., Cardenes H.R., Baron A., Gaspar L.E. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 2005, 62:1371-1378.
27. Sherman D.M., Weichselbaum R., Order S.E., Cloud L., Trey C., Piro A.J. Palliation of hepatic metastasis. Cancer 1978, 41:2013-2017.
28. Guide des procédures de radiothérapie externe 2007. Cancer Radiother 2008, 12:143-313. Société française de radiothérapie oncologique.
29. Tse R.V., Hawkins M., Lockwood G., Kim J.J., Cummings B., Knox J., et al. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol 2008, 26:657-664. [Epub 2008 Jan 2. Erratum in: J Clin Oncol 2008;26(23):3911-12].
30. Turek-Maischeider M., Kazem I. Palliative irradiation for liver metastases. JAMA 1975, 232:625-628.
31. Zaider M., Amols H.I. Practical considerations in using calculated healthy - tissue complication probabilities for treatment - plan optimization. Int J Radiat Oncol Biol Phys 1999, 44:439-447.